DAXOR CORPORATION - CLOSED END FUND
8.6075
04-10月-24 11:52:20
15 分の遅延
株式
-0.3525
-3.93%
本日の幅
8.6075 - 9.0050
ISIN
N/A
ソース
NASDAQ
-
28 8 2023 15:05:00 提供 Nasdaq GlobeNewswire
-
JACC-HF Reports Successful Heart Failure Trial With Daxor BVA-100®
10 8 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
12 7 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
11 7 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
05 7 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Daxor Corporation Announces Partial Exercise of Over-Allotment Option in Secondary Offering
22 6 2023 15:15:00 提供 Nasdaq GlobeNewswire
-
20 6 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
Daxor Accelerates Blood Volume Analysis Adoption with the Launch of ezBVA Lab Services
15 6 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
Daxor Corporation to Participate in the Maxim Group Virtual Healthcare Conference
12 6 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
Daxor Corporation Announces Closing of $4.0 Million Underwritten Public Offering
25 5 2023 14:37:00 提供 Nasdaq GlobeNewswire
-
Daxor Corporation Announces Pricing of $4.0 Million Underwritten Public Offering
22 5 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
Daxor Corporation Announces Proposed Underwritten Public Offering
19 5 2023 15:53:00 提供 Nasdaq GlobeNewswire
-
18 5 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
13 4 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
27 3 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
23 3 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
Pilot Randomized Controlled Trial Validates Daxor BVA-100® Diagnostic for Heart Failure Patients
23 3 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
03 3 2023 07:00:00 提供 Nasdaq GlobeNewswire